Evidence map›Paper›PMID 37033161›Full record

ArticleGenetics research2023

Novel KDM2B/SAV1 Signaling Pathway Promotes the Progression of Gastric Cancer.

Ning Li, Haifei Song, Zhiqin Chen, Chen Chen, Ming Quan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genetics research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ning LiDepartment of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0003-1057-7703
Haifei SongDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-3272-2425
Zhiqin ChenDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0003-4050-1689
Chen ChenDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-9810-3619
Ming QuanDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-0828-1324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvador homologue 1 (SAV1), which is reported to act as a tumor suppressor in different types of cancer, is one of the key components of the Hippo pathway. However, the expression and mechanisms of SAV1 in the development and progression of gastric cancer (GC) remain to be elucidated. Immunohistochemistry (IHC) was performed in the present study to assess the expression levels of SAV1 and lysine-specific demethylase 2B (KDM2B) in GC tissues. The biological effects of SAV1 on GC cell proliferation, migration, and invasion were studied

Indexed as

Stomach NeoplasmsCell Cycle ProteinsCell ProliferationGene Expression Regulation, NeoplasticHippo Signaling PathwayHumansLymphatic MetastasisSignal TransductionCell Cycle ProteinsSAV1 protein, human

Identifiers

PMID37033161
PMCPMC10081913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.